Onco-Innovations signs LOI with Ifowonco for LAG-3 inhibitor licence
Onco-Innovations (as listed in the alert) enters into a LOI with Ifowonco for an exclusive option and worldwide licence tied to a LAG-3 small-molecule inhibitor program.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.